occupational hiv exposure prophylaxis n.
Skip this Video
Download Presentation
Occupational HIV Exposure Prophylaxis

Loading in 2 Seconds...

play fullscreen
1 / 29

Occupational HIV Exposure Prophylaxis - PowerPoint PPT Presentation

  • Uploaded on

Occupational HIV Exposure Prophylaxis. Dr Truong Anh Tan June 30 th , 2010. Infected post-exposure rate/1000. Blood infusion 900 IDU (shared needle) 6,7 Anal sex receiver 5,0 Needlestick 3,0 Vaginal sex female 1,0 Anal sex giver 0,65 Vaginal sex male 0,5

I am the owner, or an agent authorized to act on behalf of the owner, of the copyrighted work described.
Download Presentation

PowerPoint Slideshow about 'Occupational HIV Exposure Prophylaxis' - aiko-blevins

Download Now An Image/Link below is provided (as is) to download presentation

Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author.While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server.

- - - - - - - - - - - - - - - - - - - - - - - - - - E N D - - - - - - - - - - - - - - - - - - - - - - - - - -
Presentation Transcript
occupational hiv exposure prophylaxis

Occupational HIV Exposure Prophylaxis

Dr Truong Anh Tan

June 30th , 2010

infected post exposure rate 1000
Infected post-exposure rate/1000
  • Blood infusion 900
  • IDU (shared needle) 6,7
  • Anal sex receiver 5,0
  • Needlestick 3,0
  • Vaginal sex female 1,0
  • Anal sex giver 0,65
  • Vaginal sex male 0,5
  • Oral sex receiver 0,1
  • Oral sex giver 0,05
estimated pathogen specific seroconversion rate per exposure for occupational needlestick injury
Estimated Pathogen-Specific Seroconversion Rate Per Exposure for Occupational Needlestick Injury


AETC http://depts.washington.edu/hivaids

type of exposure way involved in transmission of hiv to health care workers
Type of Exposure Way Involved in Transmission of HIV to Health Care Workers

AETC http://depts.washington.edu/hivaids

source of hiv involved in hiv transmission to health care worker
Source of HIV Involved in HIV Transmission to Health Care Worker

AETC http://depts.washington.edu/hivaids

other possible risk factors
Other Possible Risk Factors

Hollow bore vs solid bore

No documented cases to date of seroconversion from suture needles

Glove use

50% decrease in volume of blood transmitted

Mucous membrane exposure

Mosquitoes bite?

standard precautions
Standard Precautions


Standards developed to prevent exposure and transmission of disease in occupational setting

Provide guidance for the safe handling of infectious material

components of standard precautions
Components of Standard Precautions

Hand washing

Use protective barriers when indicated

Gloves: mucus membranes, body fluids, broken skin

Goggles: procedures

Masks: procedures

components of standard precautions 2
Components of Standard Precautions (2)

Sharps and waste - handle with gloves and dispose in designated containers



Suture material



Anything contaminated with any body fluid

handling with disposing sharps
Handling with Disposing Sharps

Do not recap needles!

Put containers within arms reach

Use adequate light source when treating patients

Wear heavy-duty gloves when transporting sharps

Incinerate used needles to a sufficient temperature to melt

Keep sharps out of reach of children

components of standard precautions 3
Components of Standard Precautions (3)

Re-usable instruments  must be thoroughly disinfected


Surgical tools


Immunizations for Healthcare Workers

Hepatitis A and B

recommended antiseptic solutions
Recommended Antiseptic Solutions

Alcohol 70%

Chlorhexidine, 2-4% (e.g. Hibtane, Hibiscrub)

Iodine 3%

Iodophores 7.5-10% (e.g. Betadine)

recommended disinfectants
Recommended Disinfectants

Chlorine, 0.5% (Barkina)

Sedex and Ghion brands contain 5% Chlorine, dilute for use

Glutaraldehyde, 2-4% (e.g. Cidex)

Formaldehyde, 8%

Hydrogen peroxide, 6%

Soak the instrument for 20 minutes after decontamination and cleaning

management of occupational exposure
Management of Occupational Exposure
  • HIV AB: for both (giver and receiver)
  • Hepatitis : B & C
  • CBC
  • Blood Glucose
  •  136th month
diagnostic testing
Diagnostic Testing

1 mil




HIV-1 Antibodies
















Image courtesy of The Center for AIDS Information & Advocacy, www.centerforaids.org

the early stages of hiv infection
The Early Stages of HIV Infection

Cell free HIV


Immature Dendritic cell


Skin or mucosa

Via lymphatics or circulation

Burst of HIV replication

24 hours

48 hours

HIV co-receptors, CD4 + chemokine receptor CC5

Mature Dendritic cell in regional LN undergoes a single replication, which transfers HIV toT-cell

  • Selective of macrophage-tropic HIV
wound care
Wound Care

Gently wash wounds with soap and water/ 5 minutes  alchol 70% 5 minutes (don’t scrub vigorously)

Allow wounds to bleed freely

Irrigate exposed mucosal surfaces with sterile saline

post exposure prophylaxis pep
Post Exposure Prophylaxis (PEP)


Use of therapeutic agent to prevent establishment of infection following exposure either occupationally or non-occupationally to pathogen

Roles in Occupational Exposure:

HIV prevention

HBV prevention

 Tests before ARVs therapy

step 1 does this patient need hiv pep
Step 1: Does This Patient Need HIV PEP?

Source patient

Unknown / Unwilling to get tested*



High back-ground risk

Low back-ground risk




*CDC recom: usually PEP unnecessary; consider use if source patient is high risk

step 2 determine hiv status code of source hiv sc
Step 2: Determine HIV Status Code of Source (HIV SC)

HIV Negative

HIV Positive

Asymptomatic/high CD4 = HIV SC 1

Advanced disease,primary infection or low CD4 =HIV SC 2

HIV Status Unknown or Source Unknown

= HIV SC Unknown


No PEP or + PEP with 2 drugs


occupational hiv pep
Occupational HIV PEP

2 drug regimen

Zidovudine plus lamivudine (combivir)

Stavudine plus Lamivudine

Tenofovir plus lamivudine

3 drug regimen

LPV/r or Indinivr or Nelfinavir plus NRTI backbone

Efavirez plus NRTI backbone

Consider resistance potential of source patient

Don’t use NVP (hepatotoxic)

When to start  ASAP

PEP no efficacy after 72 hours

pep guideline from moh
PEP Guideline from MOH

-PEP 1: AZT + 3TC

AZT: 300mg bid & 3TC: 150 mg bid.

-  PEP 2: 3TC + d4T

3TC: 150mg bid & d4T: 30-40mg bid.

< 60 kg, d4T: 30 mg bid.

> 60 kg, d4T: 40 mg bid.


advanced pep for high risk
Advanced PEP(for high risk)

PEP 1 or 2 plus 1of following agents:

- NFV: 1,25 g bid.

- EFV: 300 mg bid

- LPV/r: 500 mg bid (recommended)

 28 days duration

(MOH guideline for PEP updated on 9/2009)

follow up hiv testing

-CDC: HIV Ab at 6th week, 3rd month, 6th month

-Extended HIV Ab testing at 12 months recommended if a source patient co-infected HCV

VL testing not recommended unless Primary HIV Infection (PHI) suspected

-Early diagnosis: HIV RNA PCR at 3th week

Follow-up HIV Testing

MMWR June 29, 2001 / 50(RR11);1-42.

Thank you for

your attention!